BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30217375)

  • 1. Effect of Pitavastatin Compared with Atorvastatin andRosuvastatin on New-Onset Diabetes Mellitus in PatientsWith Acute Myocardial Infarction.
    Choi JY; Choi CU; Hwang SY; Choi BG; Jang WY; Kim DY; Kim W; Park EJ; Lee S; Na JO; Kim JW; Kim EJ; Rha SW; Park CG; Seo HS; Chae SC; Kim YJ; Cho MC; Kim CJ; Kim HS; Jeong MH;
    Am J Cardiol; 2018 Sep; 122(6):922-928. PubMed ID: 30217375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New onset diabetes mellitus and cardiovascular events in Korean patients with acute myocardial infarction receiving high-intensity statins.
    Choi JY; Choi CU; Choi BG; Park Y; Kang DO; Jang WY; Kim W; Na JO; Kim JW; Kim EJ; Rha SW; Park CG; Seo HS; Jeong MH; Chae SC; Seong IW; Yoon CH; Cha KS; Oh SK;
    BMC Pharmacol Toxicol; 2021 Feb; 22(1):11. PubMed ID: 33541430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases.
    Seo WW; Seo SI; Kim Y; Yoo JJ; Shin WG; Kim J; You SC; Park RW; Park YM; Kim KJ; Rhee SY; Park M; Jin ES; Kim SE
    Cardiovasc Diabetol; 2022 May; 21(1):82. PubMed ID: 35606846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins and risk for new-onset diabetes mellitus: A real-world cohort study using a clinical research database.
    Yoon D; Sheen SS; Lee S; Choi YJ; Park RW; Lim HS
    Medicine (Baltimore); 2016 Nov; 95(46):e5429. PubMed ID: 27861386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-World Analyses of the Safety Outcome among a General Population Treated with Statins: An Asian Population-Based Study.
    Lin JL; Chen PS; Lin HW; Tsai LM; Lin SH; Li YH
    J Atheroscler Thromb; 2022 Aug; 29(8):1213-1225. PubMed ID: 34497171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins.
    Kang J; Kim YC; Park JJ; Kim S; Kang SH; Cho YJ; Yoon YE; Oh IY; Yoon CH; Suh JW; Cho YS; Youn TJ; Chae IH; Choi DJ
    Cardiovasc Diabetol; 2018 Jan; 17(1):10. PubMed ID: 29325562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus.
    Giustino G; Colantonio LD; Brown TM; Carson AP; Dai Y; Farkouh ME; Monda KL; Muntner P; Rosenson RS
    Cardiovasc Drugs Ther; 2018 Oct; 32(5):453-461. PubMed ID: 30078077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study.
    Liu WT; Lin C; Tsai MC; Cheng CC; Chen SJ; Liou JT; Lin WS; Cheng SM; Lin CS; Tsao TP
    Biomedicines; 2020 Nov; 8(11):. PubMed ID: 33202854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
    Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH
    J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Statins Counteract the Effect of Antidiabetic Drugs? Results of the SCEAD Study.
    Tarim BA; Fici F; Tengiz I; Avunduk S; Ozcan Y; Faikoglu G; Ari E; Robles NR; Grassi G
    Yonsei Med J; 2023 Mar; 64(3):175-180. PubMed ID: 36825343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost-effectiveness of rosuvastatin versus simvastatin, atorvastatin and pitavastatin in patients with high and very high cardiovascular risk in Spain].
    Cosin Sales J; Fuentes Jiménez FJ; Mantilla Morató T; Ruiz E; Becerra V; Aceituno S; Ferrario MG; Lizán L; Gracia A
    Clin Investig Arterioscler; 2015; 27(5):228-38. PubMed ID: 25640158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of low dose atorvastatin on development of new-onset diabetes mellitus in Asian population: Three-year clinical outcomes.
    Park JY; Rha SW; Choi B; Choi JW; Ryu SK; Kim S; Noh YK; Choi SY; Akkala RG; Li H; Ali J; Xu S; Ngow HA; Lee JJ; Lee GN; Kim J; Lee S; Na JO; Choi CU; Lim HE; Kim JW; Kim E; Park CG; SeogSeo H; Oh DJ
    Int J Cardiol; 2015 Apr; 184():502-506. PubMed ID: 25756579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New onset diabetes mellitus and cardiovascular outcomes according to statin intensity in patients after drug-eluting stent implantation in Asian patients.
    Chung J; Kim HL; Lim WH; Seo JB; Zo JH; Kim MA; Kim SH
    Sci Rep; 2023 Sep; 13(1):16061. PubMed ID: 37749120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of High-Intensity Statins in the Veteran Population: Atorvastatin 40 to 80 mg Compared With Rosuvastatin 20 to 40 mg.
    Stein B; Ward T; Hale G; Lyver E
    Ann Pharmacother; 2020 May; 54(5):405-413. PubMed ID: 31718234
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of different doses of atorvastatin, rosuvastatin, and simvastatin on elderly patients with ST-elevation acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI).
    He W; Cao M; Li Z
    Drug Dev Res; 2020 Aug; 81(5):551-556. PubMed ID: 32142170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of diabetes in patients treated with HMG-CoA reductase inhibitors.
    Cho Y; Choe E; Lee YH; Seo JW; Choi Y; Yun Y; Wang HJ; Ahn CW; Cha BS; Lee HC; Kang ES
    Metabolism; 2015 Apr; 64(4):482-8. PubMed ID: 25312577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a hydrophilic and a hydrophobic statin on cardiac salvage after ST-elevated acute myocardial infarction - a pilot study.
    Chitose T; Sugiyama S; Sakamoto K; Shimomura H; Yamashita T; Hokamaki J; Tsunoda R; Shiraishi S; Yamashita Y; Ogawa H
    Atherosclerosis; 2014 Nov; 237(1):251-8. PubMed ID: 25262434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of statin plus ezetimibe versus high-intensity statin therapy in patients with acute myocardial infarction propensity-score matching analysis.
    Ji MS; Jeong MH; Ahn YK; Kim SH; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
    Int J Cardiol; 2016 Dec; 225():50-59. PubMed ID: 27710803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of statins in secondary prevention among the older people aged 75 years and over.
    Kwak A; Kim JH; Choi CU; Kim IW; Oh JM; Kim K
    Int J Clin Pharm; 2019 Apr; 41(2):460-469. PubMed ID: 30864086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of change in body weight on incident diabetes mellitus in patients with stable coronary artery disease treated with atorvastatin (from the treating to new targets study).
    Ong KL; Waters DD; Messig M; DeMicco DA; Rye KA; Barter PJ
    Am J Cardiol; 2014 May; 113(10):1593-8. PubMed ID: 24666618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.